Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection

Hyperinflammatory response caused by infections such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases organ failure, intensive care unit admission, and mortality. Cytokine storm in patients with Coronavirus Disease 2019 (COVID-19) drives this pattern of poor clinical outcome...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Pharmacother
Autors principals: Creeden, Justin Fortune, Imami, Ali Sajid, Eby, Hunter M., Gillman, Cassidy, Becker, Kathryn N., Reigle, Jim, Andari, Elissar, Pan, Zhixing K., O’Donovan, Sinead M., McCullumsmith, Robert E., McCullumsmith, Cheryl B.
Format: Artigo
Idioma:Inglês
Publicat: The Authors. Published by Elsevier Masson SAS. 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7904450/
https://ncbi.nlm.nih.gov/pubmed/33691249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2021.111437
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars